Preeclampsia diagnosis and management.

Eve Overton, Daniel Tobes, Allison Lee

Journal: Best practice & research. Clinical anaesthesiology 2022;36(1):107-121

PMID: 35659948

Abstract

Preeclampsia is a severe manifestation of maternal hypertensive disease affecting 2-8% of pregnancies. The disease places women at risk of women at risk of life-threatening events, including cerebral hemorrhage, pulmonary edema, acute kidney injury, hepatic failure or rupture, disseminated intravascular coagulation, eclampsia, and placental abruption. In addition to the maternal disease burden, increased fetal morbidity and mortality occurs due to iatrogenic preterm delivery, fetal growth restriction, and placental abruption. Magnesium therapy for seizure prophylaxis and blood pressure control to limit cardiovascular and cerebrovascular morbidity are the cornerstone of treatment. Interdisciplinary planning and management are crucial to optimizing patient outcomes.

Address: Columbia University Irving Medical Center, United States of America. Electronic address: [email protected].; Columbia University Irving Medical Center, United States of America. Electronic address: [email protected].; Columbia University Irving Medical Center, United States of America; Columbia University, United States of America. Electronic address: [email protected].

DOI: 10.1016/j.bpa.2022.02.003

MeSH Terms: Abruptio Placentae, Eclampsia, Female, Humans, Infant, Newborn, Placenta, Pre-Eclampsia, Pregnancy